3-deazaneplanocin has been researched along with Anoxemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Pan, YM; Rao, ZQ; Wan, SS; Yang, WJ; Yang, YN | 1 |
Angelini, GD; Caporali, A; Emanueli, C; Floris, I; Marchetti, M; Meloni, M; Mitić, T; Urrutia, R | 1 |
2 other study(ies) available for 3-deazaneplanocin and Anoxemia
Article | Year |
---|---|
Inhibition of EZH2 alleviates angiogenesis in a model of corneal neovascularization by blocking FoxO3a-mediated oxidative stress.
Topics: Adenosine; Animals; Cells, Cultured; Corneal Neovascularization; Disease Models, Animal; Enhancer of Zeste Homolog 2 Protein; Forkhead Box Protein O3; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Transcription, Genetic | 2020 |
EZH2 modulates angiogenesis in vitro and in a mouse model of limb ischemia.
Topics: Adenosine; Animals; Brain-Derived Neurotrophic Factor; Cell Hypoxia; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Femoral Artery; Hindlimb; Histones; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia; Ischemia; Male; Mice; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Polycomb Repressive Complex 2; Primary Cell Culture; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Transcription, Genetic | 2015 |